• Xilio Therapeutics granted non-qualified stock options covering 1,982 shares to one new employee, effective May 1, 2026.
• Exercise price set at USD 8.32 per share, matching May 1 closing price; options carry a 10-year term.
• Vesting set at 25% on first anniversary of employment start date; remaining 75% vests in 36 equal monthly installments, subject to continued service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605071630PRIMZONEFULLFEED9713342) on May 07, 2026, and is solely responsible for the information contained therein.